Company Search:
Advanced Search
Sponsored Links
Coland Holdings Limited Company Snapshot
Coland Holdings Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Coland Holdings Limited with three other companies in this sector in China: Lionco Pharmaceutical Group Co Ltd (2015 sales of 550.64 million Chinese Renmimbi [US$79.36 million] of which 39% was Anti-Infection), Wuyi International Pharmaceutical Company Ltd (555.65 million Chinese Renmimbi [US$80.09 million] of which 100% was Pharmaceutical Prods), and Jilin Province Huinan Changlong Bio pharmacy Co Ltd (539.13 million Chinese Renmimbi [US$77.71 million] of which 100% was Biochemical Medicine).

Sales Analysis. Coland Holdings Limited reported sales of 532.41 million Chinese Renmimbi (US$76.74 million) for the year ending December of 2015. This represents an increase of 18.9% versus 2014, when the company's sales were 447.89 million Chinese Renmimbi. Sales at Coland Holdings Limited have increased during each of the previous five years (and since 2010, sales have increased a total of 64%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Coland Holdings Limited
  Stock Performance Chart for Coland Holdings Limited
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 10.87
(Figures in Chinese Renmimbi)
1 Week 0.9%   13 Weeks -2.9%  
4 Weeks 11.6%   52 Weeks 11.5%  
Coland Holdings Limited Key Data:
  Ticker: 4144 Country: China
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 532,411,043
(Year Ending Jan 2016).
Employees: 305
  Currency: Chinese Renmimbi Market Cap: 838,388,307
  Fiscal Yr Ends: December Shares Outstanding: 77,139,000
  Share Type: Foreign Closely Held Shares: 34,676,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.